Welcome to chemicalbook!
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook > Product Catalogue >API >Antibiotics >β-Lactamase inhibitors >Doripenem hydrate

Doripenem hydrate

Doripenem hydrate Structure
  • ₹10825 - ₹43613.93
  • Product name: Doripenem hydrate
  • CAS: 364622-82-2
  • MF: C15H26N4O7S2
  • MW: 438.51
  • EINECS:680-392-3
  • MDL Number:MFCD09749887
  • Synonyms:(+)-(4r,5s,6s)-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-3-[[(3s,5s)-5-[(sulfamoylamino)-methyl]-3-pyrrolidinyl]thio]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid hydrate;doripenem hydrate;DoripeneM Crude;1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 3-[[(3S,5S)-5-[[(aminosulfonyl)amino]methyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-, hydrate;(4R,5S,6S)-6-[(1R)-1-Hydroxyethyl]-4-methyl-7-oxo-3-[(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;Doripenem monohydrate, >=99%;(4R,5S,6S)-6-((R)-1-Hydroxyethyl)-4-methyl-7-oxo-3-(((3S,5S)-5-((sulfamoylamino)methyl)pyrroli;S 4661 monohydrate
5 prices
Selected condition:

Brand

  • TCI Chemicals (India)
  • Sigma-Aldrich(India)

Package

  • 10MG
  • 25MG
  • 50MG
  • 250MG
  • ManufacturerTCI Chemicals (India)
  • Product numberD5249
  • Product descriptionDoripenem Monohydrate
  • Packaging50MG
  • Price₹11800
  • Updated2022-05-26
  • Buy
  • ManufacturerTCI Chemicals (India)
  • Product numberD5249
  • Product descriptionDoripenem Monohydrate
  • Packaging250MG
  • Price₹28800
  • Updated2022-05-26
  • Buy
  • ManufacturerSigma-Aldrich(India)
  • Product numberSML1220
  • Product descriptionDoripenem hydrate ≥98% (HPLC)
  • Packaging10MG
  • Price₹10825
  • Updated2022-06-14
  • Buy
  • ManufacturerSigma-Aldrich(India)
  • Product number32138
  • Product descriptionDoripenem monohydrate VETRANAL?, analytical standard
  • Packaging25MG
  • Price₹15241.6
  • Updated2022-06-14
  • Buy
  • ManufacturerSigma-Aldrich(India)
  • Product numberSML1220
  • Product descriptionDoripenem hydrate ≥98% (HPLC)
  • Packaging50MG
  • Price₹43613.93
  • Updated2022-06-14
  • Buy
Manufacturer Product number Product description Packaging Price Updated Buy
TCI Chemicals (India) D5249 Doripenem Monohydrate 50MG ₹11800 2022-05-26 Buy
TCI Chemicals (India) D5249 Doripenem Monohydrate 250MG ₹28800 2022-05-26 Buy
Sigma-Aldrich(India) SML1220 Doripenem hydrate ≥98% (HPLC) 10MG ₹10825 2022-06-14 Buy
Sigma-Aldrich(India) 32138 Doripenem monohydrate VETRANAL?, analytical standard 25MG ₹15241.6 2022-06-14 Buy
Sigma-Aldrich(India) SML1220 Doripenem hydrate ≥98% (HPLC) 50MG ₹43613.93 2022-06-14 Buy

Properties

Melting point :173°C(dec.)(lit.)
storage temp. :2-8°C
solubility :H2O: soluble5mg/mL, clear (warmed)
form :powder
color :white to beige
PH :Dissolve 0.3g of Doripenem Hydrate in 30mL of water: the pH of the solution is between 4.5 and 6.0.
BRN :15340136
InChIKey :NTUBEBXBDGKBTJ-WGLOMNHJSA-N
CAS DataBase Reference :364622-82-2(CAS DataBase Reference)

Safety Information

Symbol(GHS): GHS hazard pictograms
Signal word: Warning
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
H341 Suspected of causing genetic defects Germ cell mutagenicity Category 2 Warning P201,P202, P281, P308+P313, P405,P501
Precautionary statements:
P201 Obtain special instructions before use.
P202 Do not handle until all safety precautions have been read and understood.
P281 Use personal protective equipment as required.
P308+P313 IF exposed or concerned: Get medical advice/attention.
P405 Store locked up.
P501 Dispose of contents/container to..…

Description

Doripenem hydrate is a carbapenem derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of infections such as HOSPITAL-ACQUIRED PNEUMONIA, and complicated intra-abdominal or urinary-tract infections, including PYELONEPHRITIS.
Doripenem hydrate was first approved by Pharmaceuticals and Medical Devices Agency of Japan (PMDA) on July 25, 2005, then approved by the U.S. Food and Drug Administration (FDA) on Oct 12, 2007, and approved by European Medicines Agency (EMA) on July 25, 2008. It was developed by Shionogi and Janssen, then marketed as Finibax® in Japan and as Doribax® in the US by Shionogi and as Doribax® by Janssen in BE.

Related product price